• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MHC I类分子对肽段的选择

Peptide selection by MHC class I molecules.

作者信息

Schumacher T N, De Bruijn M L, Vernie L N, Kast W M, Melief C J, Neefjes J J, Ploegh H L

机构信息

Department of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam.

出版信息

Nature. 1991 Apr 25;350(6320):703-6. doi: 10.1038/350703a0.

DOI:10.1038/350703a0
PMID:1708852
Abstract

Synthetic peptides have been used to sensitize target cells and thereby screen for epitopes recognized by T cells. Most epitopes of cytotoxic T lymphocytes can be mimicked by synthetic peptides of 12-15 amino acids. Although in specific cases, truncations of peptides improves sensitization of target cells, no optimum length for binding to major histocompatibility complex (MHC) class I molecules has been defined. We have now analysed synthetic peptide captured by empty MHC class I molecules of the mutant cell line RMA-S. We found that class I molecules preferentially bound short peptides (nine amino acids) and selectively bound these peptides even when they were a minor component in a mixture of longer peptides. These results may help to explain the difference in size restriction of T-cell epitopes between experiments with synthetic peptides and those with naturally processed peptides.

摘要

合成肽已被用于使靶细胞致敏,从而筛选出被T细胞识别的表位。细胞毒性T淋巴细胞的大多数表位可被12 - 15个氨基酸的合成肽模拟。尽管在特定情况下,肽的截短可提高靶细胞的致敏性,但尚未确定与主要组织相容性复合体(MHC)I类分子结合的最佳长度。我们现在分析了突变细胞系RMA - S的空MHC I类分子捕获的合成肽。我们发现I类分子优先结合短肽(九个氨基酸),并且即使它们是较长肽混合物中的次要成分,也能选择性地结合这些肽。这些结果可能有助于解释在合成肽实验和天然加工肽实验之间T细胞表位大小限制的差异。

相似文献

1
Peptide selection by MHC class I molecules.MHC I类分子对肽段的选择
Nature. 1991 Apr 25;350(6320):703-6. doi: 10.1038/350703a0.
2
In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.通过工程化抗原呈递细胞在体外启动细胞毒性T淋巴细胞针对低免疫原性表位的反应。
Eur J Immunol. 1994 Nov;24(11):2691-8. doi: 10.1002/eji.1830241118.
3
Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.与MHC I类分子结合的肽的免疫原性取决于MHC-肽复合物的稳定性。
J Immunol. 1996 May 1;156(9):3308-14.
4
In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
Eur J Immunol. 1992 Dec;22(12):3085-90. doi: 10.1002/eji.1830221209.
5
Identification of T-cell epitopes using allele-specific ligand motifs.使用等位基因特异性配体基序鉴定T细胞表位
Behring Inst Mitt. 1994 Dec(95):7-13.
6
Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.肽工程技术可实现针对人乳头瘤病毒肿瘤抗原E6的细胞毒性T细胞疫苗接种。
Immunology. 1995 Feb;84(2):298-303.
7
Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules.
Eur J Immunol. 1992 Jun;22(6):1405-12. doi: 10.1002/eji.1830220612.
8
Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses.激活细胞毒性T细胞反应所需的肽 - 主要组织相容性复合体I类复合物数量的变化。
J Immunol. 1995 Jan 15;154(2):567-76.
9
A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.一种用于测量免疫原性肽与纯化的I类主要组织相容性复合体分子之间相互作用的定量检测方法。
Eur J Immunol. 1994 Feb;24(2):385-92. doi: 10.1002/eji.1830240218.
10
Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.I类限制性同种异体反应性细胞毒性T淋巴细胞识别一系列复杂的特定MHC相关肽。
J Immunol. 1998 Feb 1;160(3):1091-7.

引用本文的文献

1
pMHChat, characterizing the interactions between major histocompatibility complex class II molecules and peptides with large language models and deep hypergraph learning.pMHChat:利用大语言模型和深度超图学习表征主要组织相容性复合体II类分子与肽之间的相互作用
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf321.
2
Peptides for Vaccine Development.用于疫苗开发的肽。
ACS Appl Bio Mater. 2022 Mar 21;5(3):905-944. doi: 10.1021/acsabm.1c01238. Epub 2022 Feb 23.
3
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
一种针对 II 类 MHC 的疫苗可引发针对 SARS-CoV-2 及其变体的免疫反应。
Proc Natl Acad Sci U S A. 2021 Nov 2;118(44). doi: 10.1073/pnas.2116147118.
4
Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions.硫醇蛋白酶的生化和生物学意义:过去、现在和未来的方向。
Biomolecules. 2020 Aug 24;10(9):1229. doi: 10.3390/biom10091229.
5
In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever.针对拉沙热出血热的疫苗候选表位的计算机识别。
Sci Rep. 2020 May 6;10(1):7667. doi: 10.1038/s41598-020-63640-1.
6
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein.用于绘制蛋白质中Qa-1表位的重叠肽库
J Vis Exp. 2017 Dec 20(130):56401. doi: 10.3791/56401.
7
Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.双重非连续肽占据 HLA Ⅰ类分子可引发抗病毒的人 CD8+ T 细胞反应,并与自身抗原形成新表位。
Sci Rep. 2017 Jul 11;7(1):5072. doi: 10.1038/s41598-017-05171-w.
8
Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.在非肥胖糖尿病(NOD)小鼠模型中鉴定用于治疗1型糖尿病的候选耐受性CD8(+) T细胞表位
J Diabetes Res. 2016;2016:9083103. doi: 10.1155/2016/9083103. Epub 2016 Mar 16.
9
TCRβ repertoire of CD4+ and CD8+ T cells is distinct in richness, distribution, and CDR3 amino acid composition.CD4+和CD8+ T细胞的TCRβ库在丰富度、分布及CDR3氨基酸组成方面存在差异。
J Leukoc Biol. 2016 Mar;99(3):505-13. doi: 10.1189/jlb.6A0215-071RR. Epub 2015 Sep 22.
10
Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.杜氏利什曼原虫重组NAD依赖型SIR-2蛋白:作为抗内脏利什曼病潜在疫苗的免疫生化特性
PLoS Negl Trop Dis. 2015 Mar 6;9(3):e0003557. doi: 10.1371/journal.pntd.0003557. eCollection 2015 Mar.